Analgesic Efficiency of Erector Spinae Plane Block Versus Thoracic Paravertebral Block in Patients Undergoing Lateral Thoracotomy Using Opoid Sparing Anesthesia

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorCairo University

About this trial

AimoftheWork To assess the efficiency of Opoid free anaesthesia with paravertebral block compared to opoid free anaesthesia with erector spinae plane block in patients undergoing Thoracotomy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients age between 18 and 70 .

Patients with ASAII and IIIstatus.

Patients undergoing open surgical Thoracotomy as in lobectomy, pneumonectomy, segmentectomy and decortication.

Gender both males and females.

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Group A :Thoracic paravertebral block

    Procedure/Surgery

    Ultrasound guided thoracic paravertebral block performed at the T5 level using 20 ml of 0.5% bupivacaine for postoperative analgesia in patients undergoing lateral thoracotomy

  • Erector Spinae Plane Block

    Procedure/Surgery

    ultrasound guided erector spinae plane block will be performed at the T5 level using 20 ml of 0.5% bupivacaine as part of an opoid sparing anesthesia protocol for lateral thoracotomy

Treatment groups

86 Participants
are divided into 2 treatment groups
Group A: Group A : thoracic para vertebral blockExperimental treatment 1 intervention
Group B: Group B : erector spinae plane blockExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Total morphine consumption for the first 24 hours postoperative

Time frame
Within the first 24 hours postoperative

Secondary outcomes

1

Postoperative pain

Postoperative pain will be assessed using vas score at 0,2,6,12,24 hours post operative

Time frame
At 0,2,6,12,24 hours post operative

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: